Related Experiment Video
Updated: May 20, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Predictive Value of Uric Acid-to-Albumin Ratio for Left Atrial Thrombus or Spontaneous Echo Contrast in Patients with
Xiangzhu Meng1, Yuhang Wen1, Xiangying Wang2
1Department of Cardiology, Institute of Cardiovascular Diseases, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, People's Republic of China.
Insights
The uric acid-to-albumin ratio (UAR) predicts left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients. UAR offers improved risk assessment beyond the CHA2DS2-VASc score.
Area of Science:
- Cardiology
- Biomarkers
- Medical Diagnostics
Background:
- The uric acid-to-albumin ratio (UAR) is an emerging inflammatory marker associated with cardiovascular disease.
- Left atrial thrombus or spontaneous echo contrast (LAT/SEC) is a significant complication in non-valvular atrial fibrillation (NVAF).
- Existing risk stratification scores may not fully capture the risk of LAT/SEC in NVAF patients.
Purpose of the Study:
- To assess the predictive capability of UAR for LAT/SEC in NVAF patients.
- To investigate the underlying mechanisms linking UAR to LAT/SEC.
- To determine if UAR provides added predictive value beyond the established CHA2DS2-VASc score.
Main Methods:
- Retrospective analysis of 514 NVAF patients undergoing transesophageal echocardiography (TEE).
- Statistical methods included multivariable logistic regression, restricted cubic splines, generalized additive models, ROC curves, and mediation analyses.
- Reclassification indices were used to evaluate the incremental value of UAR over the CHA2DS2-VASc score.
Main Results:
- UAR was independently and non-linearly associated with LAT/SEC (OR: 1.43).
- A UAR threshold of 12.11 indicated a significantly increased risk.
- UAR demonstrated superior predictive performance (AUC=0.712) compared to uric acid or albumin alone and improved risk stratification when added to the CHA2DS2-VASc model.
Conclusions:
- UAR is a significant independent predictor of LAT/SEC in NVAF patients.
- UAR offers incremental predictive value beyond the CHA2DS2-VASc score for LAT/SEC.
- UAR may serve as a practical biomarker for refining risk assessment and guiding anticoagulation therapy in NVAF.
Background:
The uric acid-to-albumin ratio (UAR) is a novel inflammatory marker linked to cardiovascular disease. This study aimed to evaluate the predictive value of UAR for left atrial thrombus or spontaneous echo contrast (LAT/SEC) in non-valvular atrial fibrillation (NVAF), explore its mediating mechanisms, and assess the incremental value beyond the CHA2DS2-VASc score.
Methods:
This retrospective study included 514 patients with NVAF undergoing transesophageal echocardiography (TEE). Multivariable logistic regression, restricted cubic splines (RCS), generalized additive models (GAMs), receiver operating characteristic (ROC) curves, and mediation analyses were employed to evaluate the relationship between UAR and LAT/SEC. Reclassification indices assessed UAR's incremental value beyond the CHA2DS2-VASc score.
Results:
The prevalence of LAT/SEC was 17.32%. UAR was independently associated with LAT/SEC (OR: 1.43, 95% CI: 1.25-1.66; P < 0.001) in a nonlinear manner (P for non-linearity = 0.031). A threshold effect was identified at 12.11, below which the risk increased more significantly (OR: 1.61, 95% CI: 1.36-1.92; P < 0.001). UAR showed better predictive performance (AUC=0.712) than UA (0.684) and albumin (0.612). Incorporating UAR into the CHA2DS2-VASc model improved risk stratification. Mediation analysis indicated that left atrial diameter (LAD) and left ventricular ejection fraction (LVEF) accounted for 8.26% and 9.75% of the association, respectively.
Conclusion:
UAR is an independent predictor of LAT/SEC in patients with NVAF, outperforming its individual components and providing significant incremental value beyond the CHA2DS2-VASc score. It may serve as a readily accessible biomarker for optimizing risk stratification and clinical anticoagulation decisions.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Dysrhythmias V: Evaluating Dysrhythmias
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Imaging Studies for Cardiovascular System II:Types of Echocardiography
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for diagnosing...